Center for Advanced Gastroenterology

Maitland, Florida 32751

0 studies enrolling now · 13 studies all time

What they study most

Chronic Idiopathic Constipation, Crohn Disease, Crohn's Disease, Diarrhea Predominant Irritable Bowel Syndrome, Hepatitis C, Chronic, Irritable Bowel Syndrome With Constipation, Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis With Liver Fibrosis, Sedation, Ulcerative Colitis

Studies at this site

• A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease — Stopped early
• An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease — Stopped early
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) — Completed
• Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease — Completed
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors — Completed
• An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation — Completed
• An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1 — Completed
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis — Completed
• 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation — Stopped early
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease — Completed
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) — Completed
• A Dose-ranging Study to Evaluate the Safety and Efficacy of LUSEDRA (Fospropofol Disodium) as an Intravenous Sedative for Diagnostic or Therapeutic Colonoscopy in Adult Special Populations — Completed